Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Sensus Healthcare (SRTS) over the last 9 years, with Q2 2025 value amounting to -$183000.0.

  • Sensus Healthcare's Interest Expenses rose 1244.02% to -$183000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$367000.0, marking a year-over-year increase of 1323.88%. This contributed to the annual value of -$932000.0 for FY2024, which is 604.84% up from last year.
  • Latest data reveals that Sensus Healthcare reported Interest Expenses of -$183000.0 as of Q2 2025, which was up 1244.02% from -$184000.0 recorded in Q1 2025.
  • Over the past 5 years, Sensus Healthcare's Interest Expenses peaked at $103000.0 during Q4 2021, and registered a low of -$382000.0 during Q4 2022.
  • Over the past 5 years, Sensus Healthcare's median Interest Expenses value was -$183500.0 (recorded in 2025), while the average stood at -$131100.0.
  • Per our database at Business Quant, Sensus Healthcare's Interest Expenses surged by 350721.14% in 2021 and then crashed by 2420000.0% in 2023.
  • Sensus Healthcare's Interest Expenses (Quarter) stood at $103000.0 in 2021, then crashed by 470.87% to -$382000.0 in 2022, then skyrocketed by 36.39% to -$243000.0 in 2023, then increased by 13.99% to -$209000.0 in 2024, then grew by 12.44% to -$183000.0 in 2025.
  • Its Interest Expenses was -$183000.0 in Q2 2025, compared to -$184000.0 in Q1 2025 and -$209000.0 in Q2 2024.